Risk of neuropsychiatric disorders in primary hyperparathyroidism: Parathyroidectomy versus nonoperative management
World Journal of Surgery · 2025-01 · 49 (1) · 106-114
DOI: 10.1002/wjs.12285 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift World Journal of Surgery, online erschienen am 14.07.2024. Verfasst von Zhixing Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Parathyroidectomy, Hyperparathyroidism, Primary. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background
Neuropsychiatric disorders frequently manifest in primary hyperparathyroidism (PHPT), yet evidence of parathyroidectomy's benefit remains mixed. We sought to compare the incidence of neuropsychiatric disorders among patients treated with parathyroidectomy versus nonoperative management.
Methods
We retrospectively reviewed our institutional administrative database for patients with PHPT. Patients with secondary hyperparathyroidism were excluded. The date of biochemical diagnosis of PHPT was designated as day 0 and new‐onset neuropsychiatric disorders were defined as conditions diagnosed after this date. The risk of new‐onset neuropsychiatric disorders in propensity score‐matched surgical and nonsurgical patients was compared using the Cox regression over a median follow‐up of 4.2 years.
Results
Our cohort included 3728 patients, predominantly female (78%) and white (63.9%), with a mean (± Standard deviation) age of 62 ± 14 years. Of these, 1704 (45.7%) underwent parathyroidectomy. After propensity score matching and adjusting for clinical characteristics, patients who had parathyroidectomy showed a reduced hazard ratio (HR) for new‐onset cognitive impairment (HR: 0.65, 95% CI: 0.47–0.91), somnolence (HR: 0.45, 95% CI: 0.23–0.9) and schizophrenia (HR: 0.08, 95% CI: 0.01–0.6), but not for anxiety (HR: 1.07, 95% CI: 0.83–1.37), depression (HR: 1.02, 95% CI: 0.77–1.36) or suicidal ideation (HR: 0.31, 95% CI: 0.04–2.71). Additionally, surgical patients were less likely to require inpatient care (0.3% vs. 1.8%, p < 0.001) for neuropsychiatric disorders.
Conclusions
Parathyroidectomy is associated with lower risks of new‐onset cognitive impairment, schizophrenia, or somnolence, indicating potential benefit of operative management in improving neuropsychiatric symptoms in patients with PHPT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Zhixing Song, Sanjana Balachandra, Christopher Wu
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
Zitieren
APA
Song, Z., Balachandra, S., Wu, C., Wang, R., Zmijewski, P., Gillis, A., Fazendin, J., Lindeman, B., & Chen, H. (2025). Risk of neuropsychiatric disorders in primary hyperparathyroidism: Parathyroidectomy versus nonoperative management. World Journal of Surgery, 49(1), 106-114. https://doi.org/10.1002/wjs.12285
Vancouver
Song Z, Balachandra S, Wu C, Wang R, Zmijewski P, Gillis A, et al. Risk of neuropsychiatric disorders in primary hyperparathyroidism: Parathyroidectomy versus nonoperative management. World Journal of Surgery. 2025;49(1):106-114. doi:10.1002/wjs.12285
BibTeX
@article{Song2025,
author = {Song, Zhixing and Balachandra, Sanjana and Wu, Christopher and Wang, Rongzhi and Zmijewski, Polina and Gillis, Andrea and Fazendin, Jessica and Lindeman, Brenessa and Chen, Herbert},
title = {Risk of neuropsychiatric disorders in primary hyperparathyroidism: Parathyroidectomy versus nonoperative management},
journal = {World Journal of Surgery},
year = {2025},
volume = {49},
number = {1},
pages = {106--114},
doi = {10.1002/wjs.12285}
}
EUVIMED